We are live on !
Find out more
Bender Robert & Associates Portfolio holdings
AUM
$525M
Turnover
26.53%
1-Year Est. Return
38.43%
This Fund
S&P 500
This Quarter Est. Return
-2.15%
1 Year Est. Return
+38.43%
3 Year Est. Return
+145.82%
5 Year Est. Return
+189.35%
10 Year Est. Return
+1,046.87%
AUM
$141M
AUM Growth
-$10.2M
(-6.7%)
Cap. Flow
-$4.64M
Cap. Flow % of AUM
Cap. Flow %
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
58.1%
Holding
48
New
–
Increased
7
Reduced
41
Closed
–
Avg Time Held
3.2
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$15.9K |
| 2 |
Eli Lilly
LLY
|
+$12.3K |
| 3 |
Duke Energy
DUK
|
+$7.66K |
| 4 |
NextEra Energy
NEE
|
+$7.17K |
| 5 |
Verizon
VZ
|
+$5.75K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$529K |
| 2 |
Protolabs
PRLB
|
+$453K |
| 3 |
Apple
AAPL
|
+$415K |
| 4 |
CELG
Celgene Corp
CELG
|
+$298K |
| 5 |
Baidu
BIDU
|
+$295K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.47% |
| 2 | Consumer Discretionary | 26.82% |
| 3 | Technology | 22.39% |
| 4 | Communication Services | 12.4% |
| 5 | Industrials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.94T
| $16.7M | 11.85% |
577,728
-14,636
| -2% | -$415K |
2013 Q2
14 quarters
|
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $10M | 7.07% |
86,200
-2,676
| -3% | -$298K |
2013 Q2
14 quarters
|
|
3
Intuitive Surgical
ISRG
$154B
| $8.64M | 6.12% |
122,634
-3,465
| -3% | -$255K |
2013 Q2
14 quarters
|
|
4
Ulta Beauty
ULTA
$27.3B
| $7.85M | 5.56% |
30,774
-589
| -2% | -$147K |
2013 Q2
14 quarters
|
|
5
Illumina
ILMN
$34.2B
| $7.35M | 5.21% |
59,029
-1,707
| -3% | -$230K |
2013 Q2
14 quarters
|
|
6
Gilead Sciences
GILD
$211B
| $6.95M | 4.92% |
97,004
-1,883
| -2% | -$140K |
2013 Q2
14 quarters
|
|
7
Amazon
AMZN
$2.66T
| $6.62M | 4.69% |
176,560
-2,920
| -2% | -$114K |
2013 Q2
14 quarters
|
|
8
Meta Platforms (Facebook)
META
$1.58T
| $6.6M | 4.68% |
57,408
-1,143
| -2% | -$140K |
2015 Q1
7 quarters
|
|
|
9
Cognizant
CTSH
$29.1B
| $5.79M | 4.1% |
103,325
-9,880
| -9% | -$529K |
2013 Q2
14 quarters
|
|
10
lululemon athletica
LULU
$12.5B
| $5.52M | 3.91% |
84,984
-2,005
| -2% | -$120K |
2013 Q2
14 quarters
|
|
|
CAVM
11
DELISTED
Cavium, Inc.
CAVM
| $4.9M | 3.47% |
78,396
-2,630
| -3% | -$152K |
2013 Q2
14 quarters
|
|
12
Vipshop
VIPS
$6.34B
| $4.23M | 2.99% |
223,084
-13,595
| -6% | -$176K |
2014 Q1
11 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$3.42T
| $4.22M | 2.99% |
109,300
-2,800
| -2% | -$109K |
2013 Q2
14 quarters
|
|
14
Starbucks
SBUX
$119B
| $4.11M | 2.91% |
74,092
-1,986
| -3% | -$110K |
2013 Q2
14 quarters
|
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.08M | 2.89% |
33,349
-634
| -2% | -$77.6K |
2013 Q2
14 quarters
|
|
16
Booking.com
BKNG
$116B
| $4.07M | 2.88% |
69,350
-1,075
| -2% | -$64.2K |
2013 Q2
14 quarters
|
|
17
AbbVie
ABBV
$510B
| $3.78M | 2.68% |
60,312
-1,130
| -2% | -$69K |
2015 Q2
6 quarters
|
|
18
Mercado Libre
MELI
$85B
| $3.76M | 2.66% |
24,088
-400
| -2% | -$66.1K |
2013 Q2
14 quarters
|
|
|
VMW
19
DELISTED
VMware, Inc
VMW
| $3.67M | 2.6% |
46,656
-1,020
| -2% | -$79.2K |
2013 Q2
14 quarters
|
|
20
Alphabet (Google) Class A
GOOGL
$3.43T
| $3.27M | 2.32% |
82,540
-4,460
| -5% | -$178K |
2015 Q4
4 quarters
|
|
21
Biogen
BIIB
$36.8B
| $2.68M | 1.9% |
9,458
-423
| -4% | -$125K |
2015 Q1
7 quarters
|
|
|
22
Baidu
BIDU
$26.2B
| $2.5M | 1.77% |
15,220
-1,736
| -10% | -$295K |
2013 Q2
14 quarters
|
|
|
23
Protolabs
PRLB
$1.6B
| $1.71M | 1.21% |
33,267
-8,638
| -21% | -$453K |
2015 Q2
6 quarters
|
|
24
Kinder Morgan
KMI
$72.9B
| $967K | 0.69% |
46,713
-1,880
| -4% | -$39.7K |
2013 Q3
13 quarters
|
|
25
Home Depot
HD
$340B
| $846K | 0.6% |
6,310
-180
| -3% | -$23.2K |
2013 Q2
14 quarters
|
|
Similar funds
A
Bender Robert & Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Bender Robert & Associates held 48 positions worth $141M, down 6.7% from $151M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Bender Robert & Associates withdrew a net $4.64M in Q4 2016, reducing 41 holdings. Its largest reduction was Cognizant, cutting an estimated $529K.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Bender Robert & Associates added an estimated $15.9K to Bristol-Myers Squibb.
- Bender Robert & Associates added most to Bristol-Myers Squibb in Q4 2016, an estimated $15.9K increase.
- Bender Robert & Associates's biggest Q4 2016 reduction was Cognizant, cutting an estimated $529K.
- Bender Robert & Associates's ten largest holdings make up 58% of its $141M portfolio in Q4 2016.
- Bender Robert & Associates opened 0 new positions and closed 0 in Q4 2016.
- Bender Robert & Associates's portfolio value fell 6.7% quarter-over-quarter to $141M.
Based on Bender Robert & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.